Single-laboratory validation of a method for the detection and/or quantification of select alkaloids in goldenseal supplements and raw materials by reversed-phase high-performance liquid chromatography

Pharmaceutical Biology

Volumn 46, Issue 1-2, 2008, Pages 135-144

  Brown, Paula N ^a   Paley, Lori A ^a   Roman, Mark C ^b   Chan, Michael ^a  

^a BRITISH COLUMBIA INSTITUTE OF TECHNOLOGY   (Canada)

^b Tampa Bay Analytical Research Inc   (United States)

Author keywords

Adulteration; Goldenseal; HPLC; Hydrastis canadensis; Method validation; Quality control

Indexed keywords

ALKALOID DERIVATIVE; BERBERINE; CANADINE; ECHINACEA EXTRACT; HYDRASTINE; PALMATINE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; TRIPALMITIN;

ACCURACY; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; ECHINACEA; HYDRASTIS; LABORATORY TEST; QUALITY CONTROL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

HYDRASTIS CANADENSIS;

EID: 38849184012     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200701735171     Document Type: Article

References (36)

1. Abourashed EA, Khan IA (2003): High-performance liquid chromatography determination of hydrastine and berberine in dietary supplements containing goldenseal. J Pharm Sci 90: 817-822.
2. American Herbal Pharmacopoeia and Therapeutic Compendium (2001): Goldenseal Root (Hydrastis canadensis): Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz, American Herbal Pharmacopoeia, pp. 10-18.
3. Anderson ML, Burney DP (1998): Validation of sample preparation procedures for botanical analysis. J AOAC Int 81: 1005-1010.
4. AOAC (2002): AOAC Guidelines for Single Laboratory Validation of Chemical Methods for Dietary Supplements and Botanicals. Gaithersburg, MD, USA, AOAC International, pp. 1-38.
5. Betz JM, Musser SM, Larkin GM (1998): Differentiation between goldenseal (Hydrastis canadensis L.) and possible adulterants by LC/MS. Proceedings of the 39th Annual Meeting of the American Society of Pharmacognosy, Orlando, FL, July 19-23.
6. Borchers AT, Keen CL, Stern JS, Gershwin EM (2000): Inflammation and Native American medicine: The role of botanicals. Am J Clin Nutr 72: 339-347.
7. Budzinzki JW, Foster BC, Vandenhoek S, Arnason JT (2000): An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7(4): 273-282.
8. Chadwick LR, Wu CD, Kinghorn KA (2001): Isolation of alkaloids from goldenseal (Hydrastis canadensis rhizomes) using pH zone refining countercurrent chromatography. J Liq Chromatogr Rel Technol 24: 2445-2453.
9. Chen CM, Chang HC (1995): Determination of berberine in plasma, urine and bile by high-performance liquid chromatography. J Chromatogr B 665: 117-123.
10. Chen YR, Wen KC, Her GR (2000): Analysis of coptisine, berberine and palmatine in adulterated Chinese medicine by capillary electrophoresis- electrospray ion trap mass spectrometry. J Chromatogr A 866: 273-280.
11. Chung B (2000): Natural Plant Extracts Export Market Opportunities in the USA. RIRDC publication no. 00/51. Barton, Australia, RIRDC.
12. Edwards DJ, Draper EJ (2003): Variations in alkaloid content of herbal products containing goldenseal. J Am Pharm Assoc 43: 419-423.
13. El Ridi MS, Khalifa K, Mamoon A (1956): The chromatographic purification and ultra-violet spectrophotometric estimation of hydrastine and berberine in fluid extract of Hydrastis. J Pharm Pharmacol 8: 602-605.
14. Gentry EJ, Jampani HB, Keshavarz-Shokri A, Morton MD, Vander Velde D, Kelikepalli H, Mitscher LA (1998): Antitubercular natural products: Berberine from the roots of commercial Hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, β-hydrastine and two new quinic acid esters, hycandinic acid esters-1 and -2. J. Nat Prod 61: 1187-1193.
15. Govindan M, Govindan G (2000): A convenient method for the determination of the quality of goldenseal. Fitoterapia 71: 232-235.
16. Horwitz W (1982): Evaluation of analytical methods used for regulation of food and drugs. Anal Chem 54:67A-76A.
17. Horwitz W, Albert R (2006): The Horwitz ratio (HorRat): A useful index of method performance with respect to precision. J AOAC I 89: 1095-1109.
18. Kim JS, Tanaka K, Shoyama Y (2004): Immunoquantitative analysis for berberine and its related compounds using monoclonal antibodies in herbal medicines. Analyst 129: 87-91.
19. Leone MG, Cometa MF, Palmery M, Saso L (1996): HPLC determination of the major alkaloids extracted from Hydrastis canadensis L. Phyther Res 10: 545-546.
20. Li W, Fitzloff JF (2002): A validated high performance liquid chromatographic method for the analysis of goldenseal. J Pharm Pharmacol 54: 435-439.
21. Lin HL, Liu TY, Wu CW, Chi CW (1996): Berberine modulates expression of MDR1 gene product and the responses of digestive track cancer cells to paclitaxel. Br J Cancer 81(3): 416-422.
22. Lloyd JU, Lloyd CG (1908): Drugs and medicines of North America: Hydrastis canadensis. Bull Lloyd Library Bot Pharm Materia Med 10(6): 76-184.
23. Long GL, Winefordner JD (1983): Limit of detection: A closer look at the IUPAC definition. Anal Chem 55: 712A-724A.
24. MacDougall D, et al. (1980): Guidelines for data acquisition and data quality evaluation in environmental chemistry. Anal Chem 52(14):2242-2249.
25. McNamara CE, Perry NB, Follett JM, Parmenter GA, Douglas JA (2004): A new glucosyl feruloyl quinic acid as a potential marker for roots and rhizomes of goldenseal, Hydrastis canadensis. J Nat Prod 67: 1818-1822.
26. Messana I, LaBua R, Galeffi C (1980): The alkaloids of Hydrastis canadensis L (Ranunculacea). Two new alkaloids: Hydrastidine and isohydrastidine. Gazz Chim Ital 110: 539-543.
27. Miyazaki H, Shirai E, Ishiashi M, Nizima K (1978): Quantitative analysis of berberine in urine samples by chemical ionization mass fragmentography. J Chromatogr 152: 79-86.
28. Scazzocchio F, Cometa MF, Palmery M (1998): Antimicrobial activity of Hydratis canadensis extract and its major isolated alkaloids. Fitoterapia 69(S5): 58-59.
29. Schieffer GW, Kohn, M (2002): HPLC Assay of Echinacea purpurea/goldenseal (Hydrastis canadensis) combinations formulations for phenolic acids, aalkylamides and alkaloids. J Liq Chromatogr Rel Technol 25(2): 263-274.
30. Schieffer GW, Pfeiffer K (2001): Pressurized liquid extraction and multiple, ultrasonically-assisted extractions of hydrastine and berberine from goldenseal (Hydrastis canadensis) with subsequent HPLC assay. J Liq Chromatogr Rel Technol 24: 2415-2427.
31. U.S. Pharmacopeia (2005): United States Pharmacopeia - National Formulary (USP 28-NF 23). Rockville, MD, The United States Pharmacopeial Convention, Inc., pp. 2389-2390.
32. Weber HA, Zart MK, Ferguson SL, Greaves JG, Clark AP, Harris RK, Overstreet D, Smith C (2001): Separation and quantitation of isoquinoline alkaloids occurring in goldenseal. J Liq Chromatogr Rel Technol 24: 87-95.
33. Weber HA, Zart MK, Hodges AE, Molloy HM, O'Brien BM, Moody LA, Clark AP, Harris RK, Overstreet JD, Smith CS (2003): Chemical comparison of goldenseal (Hydrastis canadensis L.) root powder from three commercial suppliers. J Agric Food Chem 51: 7352-7358.
34. Weber HA, Zart MK, Hodges AE, White KD, Barnes SM, Moody LA, Clark AP, Harris RK, Overstreet JD, Smith CS (2003): Method validation for determination of alkaloid content in goldenseal root powder. J AOAC Int 86: 476-483.
35. Wernimont GT (1985): Use of Statistics to Develop and Evaluate Analytical Methods. Association of Official Analytical Chemists.
36. Zeng X, Zeng X (1999): Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed Chromatogr 13(7): 442-444.